When did ELANCO ANIMAL HEALTH INC (ELAN) report earnings last quarter?
ELANCO ANIMAL HEALTH INC (ELAN) last reported earnings on 2/24/2026.
NYSE:ELAN • US28414H1032
Past quarterly earnings results for ELANCO ANIMAL HEALTH INC (ELAN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.13 | 0.11 | 15.04% | -7.14% | 1.144B | 1.115B | 2.60% | 12.16% |
| Q3 2025 | 0.19 | 0.13 | 42.93% | 46.15% | 1.137B | 1.114B | 2.06% | 10.39% |
| Q2 2025 | 0.26 | 0.20 | 30.48% | -13.33% | 1.241B | 1.211B | 2.48% | 4.81% |
| Q1 2025 | 0.37 | 0.32 | 17.01% | 8.82% | 1.193B | 1.192B | 0.08% | -1.00% |
| Q4 2024 | 0.14 | 0.15 | -8.70% | 75.00% | 1.02B | 1.03B | -0.97% | -1.45% |
| Q3 2024 | 0.13 | 0.12 | 7.92% | -27.78% | 1.03B | 1.055B | -2.37% | -3.56% |
| Q2 2024 | 0.30 | 0.25 | 22.24% | 66.67% | 1.184B | 1.174B | 0.85% | 12.02% |
| Q1 2024 | 0.34 | 0.27 | 26.41% | -24.44% | 1.205B | 1.198B | 0.58% | -4.14% |
| Q4 2023 | 0.08 | 0.11 | -26.01% | -57.89% | 1.035B | 1.022B | 1.27% | 5.50% |
| Q3 2023 | 0.18 | 0.12 | 48.43% | -10.00% | 1.068B | 1.06B | 0.75% | 4.09% |
| Q2 2023 | 0.18 | 0.05 | 269.34% | -50.00% | 1.057B | 1.056B | 0.09% | -10.04% |
| Q1 2023 | 0.45 | 0.29 | 53.01% | 25.00% | 1.257B | 1.202B | 4.58% | 2.61% |
| Q4 2022 | 0.19 | 0.13 | 45.19% | -9.52% | 981M | 1.001B | -2.00% | -11.78% |
| Q3 2022 | 0.20 | 0.16 | 23.32% | 5.26% | 1.026B | 1.053B | -2.56% | -9.28% |
| Q2 2022 | 0.36 | 0.26 | 38.95% | 28.57% | 1.175B | 1.205B | -2.49% | -8.13% |
| Q1 2022 | 0.36 | 0.36 | -0.02% | -2.70% | 1.225B | 1.244B | -1.53% | -1.37% |
| Q4 2021 | 0.21 | 0.17 | 20.26% | 75.00% | 1.112B | 1.125B | -1.16% | -2.23% |
| Q3 2021 | 0.19 | 0.17 | 12.71% | 46.15% | 1.131B | 1.105B | 2.35% | 27.14% |
| Q2 2021 | 0.28 | 0.27 | 4.51% | 211.11% | 1.279B | 1.267B | 0.95% | 118.15% |
| Q1 2021 | 0.37 | 0.23 | 59.86% | 184.62% | 1.242B | 1.183B | 4.99% | 88.84% |
| Q4 2020 | 0.12 | 0.09 | 34.67% | - | 1.137B | 1.078B | 5.51% | - |
| Q3 2020 | 0.13 | 0.12 | 5.33% | - | 889.6M | 927.52M | -4.09% | - |
| Q2 2020 | 0.09 | 0.06 | 57.34% | - | 586.3M | 601.22M | -2.48% | - |
| Q1 2020 | 0.13 | 0.24 | -46.39% | - | 657.7M | 732.78M | -10.25% | - |
Notes
ELANCO ANIMAL HEALTH INC (ELAN) last reported earnings on 2/24/2026.
ELANCO ANIMAL HEALTH INC (ELAN) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, ELANCO ANIMAL HEALTH INC (ELAN) has beaten EPS estimates in 4 out of 4 releases.